Diane Tseng

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 649 citations · Full text

Life Sciences, Immunology, Oncology +17

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition

Barzin Y. Nabet, Mohammad Shahrokh Esfahani, Everett J. Moding et al. · Cell · 2020 · 363 citations · Full text

Life Sciences, Immunology, Oncology +16

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

G‐One Ahn, Diane Tseng, Cho-Hwa Liao et al. · Proceedings of the National Academy of Sciences · 2010 · 340 citations · Full text

Medicine, Immunology, Oncology +16

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer

Justin F. Gainor, Diane Tseng, Satoshi Yoda et al. · JCO Precision Oncology · 2017 · 261 citations

Medicine, Oncology, Pharmacology +17